To hear about similar clinical trials, please enter your email below
Trial Title:
The INSPIRE-Lung Study
NCT ID:
NCT05824273
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Conditions: Keywords:
Lung cancer screening
Social media
Tailored interventions
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Screening
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
LungTalk
Description:
LungTalk is a 10-15 minute long computer-tailored health communication and
decision-making tool.
Arm group label:
Tailored health communication intervention (LungTalk)
Intervention type:
Behavioral
Intervention name:
Non-tailored intervention - Standard of practice
Description:
ACS Lung Screening Informational Video
Arm group label:
Non-tailored Intervention
Summary:
LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to
develop and test multi-level, cancer communication interventions using innovative methods
and designs. The study's long term goal is to increase lung cancer screening uptake among
appropriate, high-risk individuals nationwide.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- ≥20-pack-year smoking history;
- Individuals who currently smoke or quit smoking within the past 15 years
Exclusion Criteria:
- Previously undergone LDCT for early detection of lung cancer, have a lung nodule or
nodules that are currently being followed
- Has ever been diagnosed with lung cancer
- Individuals with impaired decision-making (because our primary outcome is
decision-making, we will not include individuals with impaired decision-making)
Gender:
All
Minimum age:
50 Years
Maximum age:
80 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Hackensack Meridian Health - Center for Discovery and Innovation
Address:
City:
Nutley
Zip:
07110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Francis Valenzona
Phone:
201-880-3400
Email:
francis.valenzona@hmh-cdi.org
Start date:
August 2, 2023
Completion date:
July 30, 2027
Lead sponsor:
Agency:
Hackensack Meridian Health
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
Hackensack Meridian Health
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05824273
